Literature DB >> 21437011

Ivermectin-dependent release of IL-1beta in response to ATP by peritoneal macrophages from P2X(7)-KO mice.

Michèle Seil, Malika El Ouaaliti, Unai Fontanils, Irantzu Gorrono Etxebarria, Stéphanie Pochet, Giulia Dal Moro, Aida Marino, Jean-Paul Dehaye.   

Abstract

The response to ATP of peritoneal macrophages from wild-type (WT) and P2X(7)-invalidated (KO) mice was tested. Low concentrations (1-100 μM) of ATP transiently increased the intracellular concentration of calcium ([Ca(2+)](i)) in cells from both mice. The inhibition of the polyphosphoinositide-specific phospholipase C with U73122 inhibited this response especially in WT mice suggesting that the responses coupled to P2Y receptors were potentiated by the expression of P2X(7) receptors. One millimolar ATP provoked a sustained increase in the [Ca(2+)](i) only in WT mice. The response to 10 μM ATP was potentiated and prolonged by ivermectin in both mice. One millimolar ATP increased the influx of extracellular calcium, decreased the intracellular concentration of potassium ([K(+)](i)) and stimulated the secretion of interleukin-1β (IL-1β) only in cells from WT mice. Ten micromolar ATP in combination with 3 μM ivermectin reproduced these responses both in WT and KO mice. The secretion of IL-1β was also increased by nigericin in WT mice and the secretory effect of a combination of ivermectin with ATP in KO mice was suppressed in a medium containing a high concentration of potassium. In WT mice, 150 μM BzATP stimulated the uptake of YOPRO-1. Incubation of macrophages from WT and KO mice with 10 μM ATP resulted in a small increase of YOPRO-1 uptake, which was potentiated by addition of 3 μM ivermectin. The uptake of this dye was unaffected by pannexin-1 blockers. In conclusion, prolonged stimulation of P2X(4) receptors by a combination of low concentrations of ATP plus ivermectin produced a sustained activation of the non-selective cation channel coupled to this receptor. The ensuing variations of the [K(+)](i) triggered the secretion of IL-1β. Pore formation was also triggered by activation of P2X(4) receptors. Higher concentrations of ATP elicited similar responses after binding to P2X(7) receptors. The expression of the P2X(7) receptors was also coupled to a better response to P2Y receptors.

Entities:  

Keywords:  Cytokines; Inflammation; Macrophages

Year:  2010        PMID: 21437011      PMCID: PMC3033504          DOI: 10.1007/s11302-010-9205-8

Source DB:  PubMed          Journal:  Purinergic Signal        ISSN: 1573-9538            Impact factor:   3.765


  37 in total

1.  Biochemical and functional evidence for heteromeric assembly of P2X1 and P2X4 subunits.

Authors:  Annette Nicke; Daniel Kerschensteiner; Florentina Soto
Journal:  J Neurochem       Date:  2005-02       Impact factor: 5.372

2.  Impact of mass treatment of onchocerciasis with ivermectin on the transmission of infection.

Authors:  H R Taylor; M Pacqué; B Muñoz; B M Greene
Journal:  Science       Date:  1990-10-05       Impact factor: 47.728

3.  Low affinity purinergic receptor modulates the response of rat submandibular glands to carbachol and substance P.

Authors:  M Métioui; H Amsallem; E Alzola; N Chaib; A Elyamani; A Moran; A Marino; J P Dehaye
Journal:  J Cell Physiol       Date:  1996-08       Impact factor: 6.384

4.  Regulation of purinergic signaling by prostaglandin E2 in murine macrophages.

Authors:  Masaaki Ito; Isao Matsuoka
Journal:  J Pharmacol Sci       Date:  2008-08-02       Impact factor: 3.337

5.  Dynamic regulation of the P2X4 receptor in alveolar macrophages by phagocytosis and classical activation.

Authors:  Leanne Stokes; Annmarie Surprenant
Journal:  Eur J Immunol       Date:  2009-04       Impact factor: 5.532

Review 6.  The P2X7 receptor: a key player in IL-1 processing and release.

Authors:  Davide Ferrari; Cinzia Pizzirani; Elena Adinolfi; Roberto M Lemoli; Antonio Curti; Marco Idzko; Elisabeth Panther; Francesco Di Virgilio
Journal:  J Immunol       Date:  2006-04-01       Impact factor: 5.422

7.  Expression of the P2X7 receptor increases the Ca2+ content of the endoplasmic reticulum, activates NFATc1, and protects from apoptosis.

Authors:  Elena Adinolfi; Maria Giulia Callegari; Maria Cirillo; Paolo Pinton; Carlotta Giorgi; Dario Cavagna; Rosario Rizzuto; Francesco Di Virgilio
Journal:  J Biol Chem       Date:  2009-02-09       Impact factor: 5.157

8.  P2Z adenosine triphosphate receptor activity in cultured human monocyte-derived macrophages.

Authors:  S E Hickman; J el Khoury; S Greenberg; I Schieren; S C Silverstein
Journal:  Blood       Date:  1994-10-15       Impact factor: 22.113

9.  P2X1 and P2X4 receptor currents in mouse macrophages.

Authors:  J A Sim; C-K Park; S B Oh; R J Evans; R A North
Journal:  Br J Pharmacol       Date:  2007-10-15       Impact factor: 8.739

10.  Mammalian P2X7 receptor pharmacology: comparison of recombinant mouse, rat and human P2X7 receptors.

Authors:  Diana L Donnelly-Roberts; Marian T Namovic; Ping Han; Michael F Jarvis
Journal:  Br J Pharmacol       Date:  2009-06-22       Impact factor: 8.739

View more
  11 in total

1.  Purinergic regulation of high-glucose-induced caspase-1 activation in the rat retinal Müller cell line rMC-1.

Authors:  Katherine E Trueblood; Susanne Mohr; George R Dubyak
Journal:  Am J Physiol Cell Physiol       Date:  2011-08-10       Impact factor: 4.249

Review 2.  ATP receptors gate microglia signaling in neuropathic pain.

Authors:  Tuan Trang; Simon Beggs; Michael W Salter
Journal:  Exp Neurol       Date:  2011-11-16       Impact factor: 5.330

Review 3.  Brain-derived neurotrophic factor from microglia: a molecular substrate for neuropathic pain.

Authors:  Tuan Trang; Simon Beggs; Michael W Salter
Journal:  Neuron Glia Biol       Date:  2012-05-22

Review 4.  P2X4 purinoceptor signaling in chronic pain.

Authors:  Tuan Trang; Michael W Salter
Journal:  Purinergic Signal       Date:  2012-04-15       Impact factor: 3.765

Review 5.  Connexins and Pannexins: New Insights into Microglial Functions and Dysfunctions.

Authors:  Rosario Gajardo-Gómez; Valeria C Labra; Juan A Orellana
Journal:  Front Mol Neurosci       Date:  2016-09-22       Impact factor: 5.639

Review 6.  Progress in Understanding the Molecular Mechanisms Underlying the Antitumour Effects of Ivermectin.

Authors:  Jian Liu; Kun Zhang; Lin Cheng; He Zhu; Tianmin Xu
Journal:  Drug Des Devel Ther       Date:  2020-01-21       Impact factor: 4.162

7.  Purinergic regulation of inflammasome activation after central nervous system injury.

Authors:  Louis-Philippe Bernier
Journal:  J Gen Physiol       Date:  2012-11       Impact factor: 4.086

8.  Modulation of P2X4/P2X7/Pannexin-1 sensitivity to extracellular ATP via Ivermectin induces a non-apoptotic and inflammatory form of cancer cell death.

Authors:  Dobrin Draganov; Sailesh Gopalakrishna-Pillai; Yun-Ru Chen; Neta Zuckerman; Sara Moeller; Carrie Wang; David Ann; Peter P Lee
Journal:  Sci Rep       Date:  2015-11-10       Impact factor: 4.379

9.  Staphylococcus aureus activates the NLRP3 inflammasome in human and rat conjunctival goblet cells.

Authors:  Victoria E McGilligan; Meredith S Gregory-Ksander; Dayu Li; Jonathan E Moore; Robin R Hodges; Michael S Gilmore; Tara C B Moore; Darlene A Dartt
Journal:  PLoS One       Date:  2013-09-10       Impact factor: 3.240

Review 10.  Potential contribution of alveolar epithelial type I cells to pulmonary fibrosis.

Authors:  Michael Kasper; Kathrin Barth
Journal:  Biosci Rep       Date:  2017-11-21       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.